ARCHIVES

R.S.K. Young Quits As FDA Oncology Group Leader

This article is from The Cancer Letter archive.

Vol. 06 No. 28 | July 11, 1980

Download PDF Visit The Full Archive

Related Articles

Reauthorization Still Held up

September 30, 1988

FDA Advisors OK Levamisole, Conditional New Tamoxifen Use

February 9, 1990

DFCI Puts The Cancer Letter On Its Intranet For Employees.

February 11, 2000

De-Emphasis of Tradition Grants Still Haunts Some; “Recent NCI Actions Held Up As Evidence

May 21, 1976

In Brief: Cancer Act, Accelerated Progress, ACS President Says; Scanners Scapegoats, EMI Chief Claimes

April 7, 1978

Trial Needed Of PSA To Determine Patients To Test, Chabner Says

March 5, 1993